-- 周五收盘时,澳大利亚股市小幅走低,投资者正等待周末美伊外交磋商的结果。 S&P/ASX 200 指数下跌 0.1%,或 8.1 点,收于 8,946.90 点。 美国总统唐纳德·特朗普宣布黎巴嫩和以色列之间停火 10 天,并表示美伊会谈可能在周末举行。布伦特原油期货价格下跌超过 1%,至每桶 98.14 美元。现货黄金价格上涨近 1%,至每盎司 4,830.82 美元。 在国内方面,据西太平洋银行的一份报告显示,澳大利亚的信用卡活动在 3 月份季度增长了 1.2%,但季度增长势头疲软,低于 2025 年 6 月、9 月和 12 月季度 2% 的平均水平。截至4月11日的三周内,西太平洋银行-DataX信用卡追踪指数下跌2.2点。 公司新闻方面,Zip(ASX:ZIP)周五公布,其第三财季税前折旧摊销前现金收益(EBTDA)为每股6510万澳元,高于去年同期的4600万澳元。该公司表示,已将2026财年集团现金EBTDA预期上调至不低于2.6亿澳元。 美国铝业公司(ASX:AAI)周五公布,其第一财季调整后每股收益为1.40澳元,低于去年同期的2.15澳元。该公司预计,2026年氧化铝业务总产量和出货量将与此前预测保持一致,分别为970万至990万吨和1180万至1200万吨。 最后,Paladin Energy(ASX:PDN)表示,目前预计其位于纳米比亚的Langer Heinrich矿2026财年的八氧化三铀产量将在450万至480万磅之间,高于此前预期的400万至440万磅。该公司股价在交易日内触及近两年来的最高点。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.